XENGLU MET XR 25+1000MG TAB

XENGLU MET XR is a combination tablet containing Empagliflozin 25mg and Metformin HCL 1000mg. This extended-release formulation is designed to help manage type 2 diabetes by improving blood sugar control through dual mechanisms of action.
Empagliflozin works by increasing glucose excretion through the kidneys, while Metformin reduces hepatic glucose production and improves insulin sensitivity. Together, these active ingredients provide comprehensive glycemic management.
Suitable for adults with type 2 diabetes when diet and exercise alone are insufficient. Each tablet delivers sustained medication release for consistent therapeutic effect throughout the day.
Always follow your healthcare provider's dosing instructions and maintain regular monitoring of blood glucose levels during treatment.